Studies have shown promise in treating Alzheimer’s and Parkinson’s with GLP-1 drugs, perhaps by regulating insulin levels and reducing inflammation, and the drugs may yet prove useful in treating many other conditions made worse by chronic inflammation. Some studies have found large decreases in the risk of depression and anxiety; others found smal... See more

A majority of people prescribed GLP-1 drugs stop using it within the first year. Maybe it’s the side effects. Maybe they miss drinking and don’t appreciate the nausea. Maybe they can’t afford the drugs. Maybe they stop after they hit their target weight. Maybe people just don’t like injectables.